Table 1.
No. | 92 | 100% |
---|---|---|
Age / years | ||
Mean (SD) | 53.6 (9.0) | |
Range | 35.0-75.5 | |
Breast cancer side | ||
Left | 46 | 50% |
Right | 46 | 50% |
BMI / kg/m2 | ||
Mean (SD) | 26.1 (4.9) | |
Range | 17.9-40.1 | |
No. of patients with BMI 25-29.9 kg/m2 | 30 | 32.6% |
No. of patients with BMI ≥ 30 kg/m2 | 16 | 17.4% |
Co-morbidities | ||
HBP | 27 | 29.3% |
DM | 4 | 4.3% |
Dyslipidaemia | 9 | 9.8% |
Treatment | ||
Cumulative dose of anthracycline | ||
Doxorubicin (mean) / mg/m2 | 240 | 10.9% |
Epidoxorubicin (mean) / mg/m2 | 304 | 89.1% |
RT | 65 | 70.7% |
ET | 60 | 65.2% |
Taxane-based chemotherapy | 82 | 89.1% |
BMI: body mass index; HBP: high blood pressure; DM: diabetes mellitus; RT: radiotherapy; ET: endocrine therapy; SD: standard deviation.